相关实验视频

Updated: May 11, 2026

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

对大脑转移的新辅助立体射线手术:目前的证据和临床前景

Aybala Nur Ucgul¹, Ahmet Oguz Tugcu¹, Ozge Petek Erpolat²

¹Department of Radiation Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.

Biomolecules & biomedicine

|September 4, 2025

概括

新辅助立体射线手术 (SRS) 对大脑转移有希望,比单独手术提供更好的局部控制和更少的并发症. 对这种先进治疗的最佳剂量和患者选择需要进一步的研究.

科学领域:

神经外科
辐射瘤学
癌症学

背景情况:

新辅助立体放射性手术 (SRS) 是大脑转移的一个不断发展的策略.
它旨在改善与传统术后辐射相比的结果.
关键的好处包括增强局部瘤控制和减少膜内扩散.

研究的目的:

审查新辅助药物SRS对大脑转移的现有证据.
将其有效性和安全性与术后SRS进行比较.
确定未来研究和优化的领域.

主要方法:

来自回顾性和前性研究的数据的整合.
结果分析,包括局部控制率,毒性和存活率.
影响治疗疗效的因素的评估.

主要成果:

新辅助的SRS表现出与手术后的SRS相当或更强的局部控制.
观察到较低的辐射死亡率和瘦骨病.
提高处理效率和减少延迟的可能性.

结论:

新辅助性SRS是一种可行的,对大脑转移有潜在的优势的方法.
进一步研究最佳剂量,时间和患者选择至关重要.
与全身疗法的整合需要进一步研究.

更多相关视频

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...